448 related articles for article (PubMed ID: 33352495)
1. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial.
Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
Phytomedicine; 2021 Jan; 81():153431. PubMed ID: 33352495
[TBL] [Abstract][Full Text] [Related]
2. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
[TBL] [Abstract][Full Text] [Related]
3. Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.
Ranasinghe P; Galappaththy P; Constantine GR; Jayawardena R; Weeratunga HD; Premakumara S; Katulanda P
Trials; 2017 Sep; 18(1):446. PubMed ID: 28962661
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
[TBL] [Abstract][Full Text] [Related]
5. A double-masked placebo-controlled trial assessing effects of various doses of BTS 67,582, a novel insulinotropic agent, on fasting hyperglycemia in NIDDM patients.
Skillman CA; Raskin P
Diabetes Care; 1997 Apr; 20(4):591-6. PubMed ID: 9096985
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluation.
Derosa G; Ragonesi PD; Fogari E; Cicero AF; Bianchi L; Bonaventura A; Romano D; Maffioli P
Fundam Clin Pharmacol; 2014 Apr; 28(2):221-9. PubMed ID: 23039403
[TBL] [Abstract][Full Text] [Related]
7. Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Naïve Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Wu W; Li Y; Chen X; Lin D; Xiang S; Shen F; Gu X
Med Sci Monit; 2015 Sep; 21():2678-84. PubMed ID: 26350766
[TBL] [Abstract][Full Text] [Related]
8. Controlling type 2 diabetes mellitus with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety.
Mirfeizi M; Mehdizadeh Tourzani Z; Mirfeizi SZ; Asghari Jafarabadi M; Rezvani HR; Afzali M
J Diabetes; 2016 Sep; 8(5):647-56. PubMed ID: 26362826
[TBL] [Abstract][Full Text] [Related]
9. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.
Vuksan V; Sung MK; Sievenpiper JL; Stavro PM; Jenkins AL; Di Buono M; Lee KS; Leiter LA; Nam KY; Arnason JT; Choi M; Naeem A
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):46-56. PubMed ID: 16860976
[TBL] [Abstract][Full Text] [Related]
10. CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
Di Prospero NA; Artis E; Andrade-Gordon P; Johnson DL; Vaccaro N; Xi L; Rothenberg P
Diabetes Obes Metab; 2014 Nov; 16(11):1055-64. PubMed ID: 24798870
[TBL] [Abstract][Full Text] [Related]
11. Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trial.
Grant SJ; Chang DH; Liu J; Wong V; Kiat H; Bensoussan A
BMC Complement Altern Med; 2013 May; 13():104. PubMed ID: 23672597
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.
Stenlöf K; Cefalu WT; Kim KA; Jodar E; Alba M; Edwards R; Tong C; Canovatchel W; Meininger G
Curr Med Res Opin; 2014 Feb; 30(2):163-75. PubMed ID: 24073995
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
[TBL] [Abstract][Full Text] [Related]
15. The effect of hydroalcoholic Saffron (Crocus sativus L.) extract on fasting plasma glucose, HbA1c, lipid profile, liver, and renal function tests in patients with type 2 diabetes mellitus: A randomized double-blind clinical trial.
Moravej Aleali A; Amani R; Shahbazian H; Namjooyan F; Latifi SM; Cheraghian B
Phytother Res; 2019 Jun; 33(6):1648-1657. PubMed ID: 30942510
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
Lian F; Tian J; Chen X; Li Z; Piao C; Guo J; Ma L; Zhao L; Xia C; Wang CZ; Yuan CS; Tong X
PLoS One; 2015; 10(6):e0130550. PubMed ID: 26098833
[TBL] [Abstract][Full Text] [Related]
18. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
19. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
